UBS AM’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.8M Buy
94,787
+23,773
+33% +$703K ﹤0.01% 1991
2025
Q1
$2.12M Buy
71,014
+4,625
+7% +$138K ﹤0.01% 1967
2024
Q4
$1.9M Buy
66,389
+7,063
+12% +$202K ﹤0.01% 2071
2024
Q3
$2.29M Sell
59,326
-9,984
-14% -$386K ﹤0.01% 1970
2024
Q2
$2.23M Buy
69,310
+38,581
+126% +$1.24M ﹤0.01% 1938
2024
Q1
$1.19M Hold
30,729
﹤0.01% 1921
2023
Q4
$946K Hold
30,729
﹤0.01% 2050
2023
Q3
$687K Hold
30,729
﹤0.01% 2160
2023
Q2
$737K Hold
30,729
﹤0.01% 2143
2023
Q1
$737K Sell
30,729
-5,927
-16% -$142K ﹤0.01% 2143
2022
Q4
$850K Buy
36,656
+6,939
+23% +$161K ﹤0.01% 1926
2022
Q3
$476K Buy
29,717
+1,558
+6% +$25K ﹤0.01% 2363
2022
Q2
$499K Sell
28,159
-556
-2% -$9.85K ﹤0.01% 2315
2022
Q1
$585K Hold
28,715
﹤0.01% 2407
2021
Q4
$536K Hold
28,715
﹤0.01% 2525
2021
Q3
$567K Hold
28,715
﹤0.01% 2452
2021
Q2
$679K Buy
28,715
+291
+1% +$6.88K ﹤0.01% 2409
2021
Q1
$674K Sell
28,424
-2,010
-7% -$47.6K ﹤0.01% 2276
2020
Q4
$610K Buy
30,434
+2,822
+10% +$56.5K ﹤0.01% 2222
2020
Q3
$575K Sell
27,612
-460
-2% -$9.58K ﹤0.01% 2080
2020
Q2
$491K Sell
28,072
-224,618
-89% -$3.93M ﹤0.01% 2135
2020
Q1
$4.13M Sell
252,690
-39,139
-13% -$639K ﹤0.01% 1112
2019
Q4
$6.01M Sell
291,829
-1,461
-0.5% -$30.1K ﹤0.01% 1115
2019
Q3
$3.37M Sell
293,290
-4,422
-1% -$50.8K ﹤0.01% 1373
2019
Q2
$3.91M Sell
297,712
-5,936
-2% -$78.1K ﹤0.01% 1286
2019
Q1
$4.6M Sell
303,648
-1,633
-0.5% -$24.7K ﹤0.01% 1182
2018
Q4
$5.24M Buy
305,281
+292,781
+2,342% +$5.03M ﹤0.01% 1082
2018
Q3
$184K Hold
12,500
﹤0.01% 2465
2018
Q2
$298K Buy
+12,500
New +$298K ﹤0.01% 2300